Mechanistic Target of Rapamycin Complex 1 (mTORC1) and mTORC2 as Key Signaling Intermediates in Mesenchymal Cell Activation
Rapamycin Reverses Lymphatic Abnormalities in a Transgenic Mouse Model of Pulmonary Lymphangiectasia
Tags: immunosuppressant, macrolide, mTOR inhibitor, prevention of organ transplant rejection, Rapamune®, sirolimus
BASi Method Number SAP.1871
Sign up and you’ll receive the latest updates that matter to you, delivered straight to your inbox.
